Biotech

All Articles

Eli Lilly dives deeper into AI along with $409M Genetic Jump package

.Eli Lilly has vaulted into an AI-enabled drug breakthrough deal, partnering along with RNA speciali...

After FDA denial as well as unemployments, Lykos CEO is leaving behind

.Lykos chief executive officer as well as owner Amy Emerson is actually leaving, with principal work...

Novartis kindles brand new phase of Voyager contract with $15M capsid package

.Novartis levels a brand new frontier in its own cooperation along with Voyager Therapeutics, paying...

Lilly posts a lot more beneficial records on its own every week blood insulin possibility

.On the heels of an FDA turndown for its chief competing Novo Nordisk, Eli Lilly is pulling ahead in...

IN 8bio stops stage 2 test, lays off one-half of staff

.Merely a handful of months after application the 1st person in a stage 2 trial for newly identified...

Lilly, Haya ink $1B biobuck obesity pact to browse darker genome

.Eli Lilly's look for weight problems intendeds has led it to the black genome. The Big Pharma has c...

ArsenalBio raises $325M, pivots far from former lead possession

.Collection Biosciences is carrying on up. The tissue treatment provider has added on $325 million i...

Lilly- backed effective weight loss biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' cannabis use medicine flunks stage 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of protecting a fast, beneficial choice on a $100 million choice repayment have...

ProKidney standstills phase 3 trial certainly not needed for cell therapy approval

.ProKidney has actually ceased one of a pair of period 3 tests for its own cell treatment for renal ...